AU2001271841A1 - Methods for identifying combinations of drugs - Google Patents
Methods for identifying combinations of drugsInfo
- Publication number
- AU2001271841A1 AU2001271841A1 AU2001271841A AU7184101A AU2001271841A1 AU 2001271841 A1 AU2001271841 A1 AU 2001271841A1 AU 2001271841 A AU2001271841 A AU 2001271841A AU 7184101 A AU7184101 A AU 7184101A AU 2001271841 A1 AU2001271841 A1 AU 2001271841A1
- Authority
- AU
- Australia
- Prior art keywords
- drugs
- methods
- identifying combinations
- identifying
- combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61183500A | 2000-07-07 | 2000-07-07 | |
US09/611,835 | 2000-07-07 | ||
PCT/US2001/021292 WO2002004946A2 (en) | 2000-07-07 | 2001-07-05 | Methods for identifying combinations of drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001271841A1 true AU2001271841A1 (en) | 2002-01-21 |
Family
ID=24450586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001271841A Abandoned AU2001271841A1 (en) | 2000-07-07 | 2001-07-05 | Methods for identifying combinations of drugs |
Country Status (20)
Country | Link |
---|---|
US (3) | US20020019010A1 (en) |
EP (2) | EP1586900A3 (en) |
JP (1) | JP3790447B2 (en) |
KR (1) | KR100470825B1 (en) |
CN (1) | CN1452719A (en) |
AR (1) | AR029581A1 (en) |
AT (1) | ATE298424T1 (en) |
AU (1) | AU2001271841A1 (en) |
BR (1) | BR0102781A (en) |
CA (1) | CA2352515C (en) |
DE (1) | DE60111595T2 (en) |
DK (1) | DK1170591T3 (en) |
ES (1) | ES2243367T3 (en) |
IL (1) | IL144049A (en) |
MX (1) | MXPA01006914A (en) |
NZ (2) | NZ524186A (en) |
PT (1) | PT1170591E (en) |
SG (1) | SG148027A1 (en) |
TW (1) | TWI240074B (en) |
WO (1) | WO2002004946A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1243327A1 (en) * | 2001-03-19 | 2002-09-25 | BioChip Technologies GmbH | Suface with a pattern of cells and method for its production |
TW573125B (en) * | 2001-08-29 | 2004-01-21 | Combinatorx Inc | A screening system for identifying drug-drug interactions and methods of use thereof |
WO2004080445A1 (en) * | 2003-03-12 | 2004-09-23 | Molecular Engines Laboratories Sa | Methods and compositions for the treatment of cancer |
DE602004027014D1 (en) | 2003-03-26 | 2010-06-17 | Synergy Biosystems Ltd | TTEL AND SYNERGISTIC COMBINATIONS |
WO2004109280A2 (en) * | 2003-06-06 | 2004-12-16 | Combinatorx Incorporated | System and method for multidimensional evaluation of combinations of compositions |
JP4632400B2 (en) | 2003-12-16 | 2011-02-16 | キヤノン株式会社 | Cell culture substrate, method for producing the same, and cell screening method using the same |
EP1694812A4 (en) * | 2003-12-16 | 2008-11-12 | Canon Kk | Biologically active substance transfer sheet, cell culture kit constituted of cell culture plate and biologically active substance transfer sheet, producing method thereof and method for screening cell culture conditions utilizing the same |
US20060040338A1 (en) * | 2004-08-18 | 2006-02-23 | Odyssey Thera, Inc. | Pharmacological profiling of drugs with cell-based assays |
EP2089723A2 (en) * | 2006-11-13 | 2009-08-19 | University of Wyoming | Apparatus and method for measuring the fluorescence of large multi-cellular organisms |
WO2009151511A1 (en) * | 2008-04-29 | 2009-12-17 | Therasis, Inc. | Systems and methods for identifying combinations of compounds of therapeutic interest |
CN104090094A (en) * | 2013-05-28 | 2014-10-08 | 长兴化学工业股份有限公司 | Biomedical device |
WO2017083729A2 (en) * | 2015-11-13 | 2017-05-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Fixatives and methods of use |
DE102020202529A1 (en) * | 2020-02-27 | 2021-09-02 | Robert Bosch Gesellschaft mit beschränkter Haftung | Method for identifying a combination of active ingredients |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5650489A (en) * | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
CA2058252A1 (en) * | 1991-03-18 | 1992-09-19 | Linda R. Robertson | Synergistic product selection test for biocides |
US5885782A (en) * | 1994-09-13 | 1999-03-23 | Nce Pharmaceuticals, Inc. | Synthetic antibiotics |
US5985356A (en) * | 1994-10-18 | 1999-11-16 | The Regents Of The University Of California | Combinatorial synthesis of novel materials |
US5756304A (en) * | 1995-07-14 | 1998-05-26 | Molecular Solutions | Screening of microorganisms for bioremediation |
US5989835A (en) * | 1997-02-27 | 1999-11-23 | Cellomics, Inc. | System for cell-based screening |
US6030942A (en) * | 1996-08-30 | 2000-02-29 | The Trustees Of The University Of Pennsylvania | Peptides peptide analogs peptidomimetics and other small molecules useful for inhibiting the activity of ribonucleotide reductase |
US5985214A (en) * | 1997-05-16 | 1999-11-16 | Aurora Biosciences Corporation | Systems and methods for rapidly identifying useful chemicals in liquid samples |
WO1998051664A1 (en) * | 1997-05-16 | 1998-11-19 | Women & Infants Hospital | 3-epi vitamin d2 compounds and uses thereof |
US5992226A (en) * | 1998-05-08 | 1999-11-30 | The United States Of America As Represented By The Secretary Of The Navy | Apparatus and method for measuring intermolecular interactions by atomic force microscopy |
US6219674B1 (en) * | 1999-11-24 | 2001-04-17 | Classen Immunotherapies, Inc. | System for creating and managing proprietary product data |
US7266458B2 (en) * | 2000-03-06 | 2007-09-04 | Bioseek, Inc. | BioMAP analysis |
-
2001
- 2001-03-22 US US09/815,417 patent/US20020019010A1/en not_active Abandoned
- 2001-03-22 US US09/815,429 patent/US20020019011A1/en not_active Abandoned
- 2001-06-28 IL IL144049A patent/IL144049A/en not_active IP Right Cessation
- 2001-07-01 NZ NZ524186A patent/NZ524186A/en unknown
- 2001-07-05 ES ES01115703T patent/ES2243367T3/en not_active Expired - Lifetime
- 2001-07-05 AT AT01115703T patent/ATE298424T1/en not_active IP Right Cessation
- 2001-07-05 WO PCT/US2001/021292 patent/WO2002004946A2/en active Application Filing
- 2001-07-05 SG SG200502530-9A patent/SG148027A1/en unknown
- 2001-07-05 KR KR10-2001-7011539A patent/KR100470825B1/en not_active IP Right Cessation
- 2001-07-05 CN CN01815353A patent/CN1452719A/en active Pending
- 2001-07-05 AU AU2001271841A patent/AU2001271841A1/en not_active Abandoned
- 2001-07-05 PT PT01115703T patent/PT1170591E/en unknown
- 2001-07-05 DK DK01115703T patent/DK1170591T3/en active
- 2001-07-05 EP EP05013343A patent/EP1586900A3/en not_active Withdrawn
- 2001-07-05 EP EP01115703A patent/EP1170591B1/en not_active Expired - Lifetime
- 2001-07-05 DE DE60111595T patent/DE60111595T2/en not_active Expired - Fee Related
- 2001-07-06 MX MXPA01006914A patent/MXPA01006914A/en active IP Right Grant
- 2001-07-06 AR ARP010103237A patent/AR029581A1/en not_active Application Discontinuation
- 2001-07-06 NZ NZ512821A patent/NZ512821A/en unknown
- 2001-07-06 CA CA002352515A patent/CA2352515C/en not_active Expired - Lifetime
- 2001-07-09 BR BR0102781-6A patent/BR0102781A/en not_active IP Right Cessation
- 2001-07-09 JP JP2001208607A patent/JP3790447B2/en not_active Expired - Fee Related
- 2001-09-21 TW TW090116629A patent/TWI240074B/en active
-
2006
- 2006-04-18 US US11/379,179 patent/US20060177877A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
TWI240074B (en) | 2005-09-21 |
EP1586900A3 (en) | 2005-12-14 |
EP1586900A2 (en) | 2005-10-19 |
ATE298424T1 (en) | 2005-07-15 |
MXPA01006914A (en) | 2004-10-15 |
BR0102781A (en) | 2002-03-12 |
DK1170591T3 (en) | 2005-10-10 |
KR20020065340A (en) | 2002-08-13 |
NZ524186A (en) | 2004-10-29 |
US20060177877A1 (en) | 2006-08-10 |
AR029581A1 (en) | 2003-07-02 |
PT1170591E (en) | 2005-11-30 |
DE60111595T2 (en) | 2006-05-18 |
JP3790447B2 (en) | 2006-06-28 |
ES2243367T3 (en) | 2005-12-01 |
IL144049A0 (en) | 2002-04-21 |
US20020019010A1 (en) | 2002-02-14 |
CA2352515A1 (en) | 2002-01-07 |
NZ512821A (en) | 2003-05-30 |
US20020019011A1 (en) | 2002-02-14 |
SG148027A1 (en) | 2008-12-31 |
KR100470825B1 (en) | 2005-03-08 |
JP2002328124A (en) | 2002-11-15 |
EP1170591B1 (en) | 2005-06-22 |
EP1170591A3 (en) | 2002-09-18 |
CA2352515C (en) | 2007-06-19 |
WO2002004946A2 (en) | 2002-01-17 |
IL144049A (en) | 2006-12-10 |
DE60111595D1 (en) | 2005-07-28 |
EP1170591A2 (en) | 2002-01-09 |
CN1452719A (en) | 2003-10-29 |
WO2002004946A3 (en) | 2003-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001240115A1 (en) | Method for the preparation of tetrahydrobenzothiepines | |
AU2001234608A1 (en) | Methods for analysis of gene expression | |
AU2002214031A1 (en) | System for withdrawing blood | |
AU2001240856A1 (en) | Capsules | |
AU2001280599A1 (en) | Compounds and methods | |
AU2001240838A1 (en) | Capsules | |
AU2001271841A1 (en) | Methods for identifying combinations of drugs | |
AU2001243394A1 (en) | Compounds and methods | |
AU2002219900A1 (en) | Minimal identification of features | |
AU2002221099A1 (en) | Combination drugs | |
AUPQ872300A0 (en) | Compounds and methods | |
AU2002214487A1 (en) | Method for inducing apoptiosis | |
AU2001220281A1 (en) | Rollerboard for road-skiing | |
AU2001213451A1 (en) | Method for preparation of polycarbonates | |
AU2002246912A1 (en) | Receptor-binding compounds and methods for identifying them | |
AU2002333276A1 (en) | Drugs for vasculopaties | |
AU2001292301A1 (en) | Novel drugs for liver diseases | |
AU2001266176A1 (en) | Methods | |
AU2001278951A1 (en) | Compounds and methods | |
AU2001250536A1 (en) | Methods | |
AU2002235277A1 (en) | Compounds and methods | |
AU2001292578A1 (en) | Pharmaceutical compounds | |
AU2002228911A1 (en) | Methods for inhibiting pain | |
AU2001246862A1 (en) | Method of detecting cancer | |
AU2001286091A1 (en) | Methods for identifying modulators of protein interactions |